Carvedilol Does Not Appear to Worsen Glycemic Control and May Improve...

"Carvedilol does not appear to worsen glycemic control and may improve some components of the metabolic syndrome in patients with diabetes and hypertension, according to the results of a randomized, double-blind, parallel-group trial published in the Nov. 10 issue of JAMA. The findings were also presented Tuesday at the American Heart Association Scientific Sessions in New Orleans"